Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Insider Helen Louise Collins Sells 5,000 Shares

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) insider Helen Louise Collins sold 5,000 shares of Bitwise MARA Option Income Strategy ETF stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $27.76, for a total transaction of $138,800.00. Following the completion of the sale, the insider directly owned 25,000 shares of the company’s stock, valued at approximately $694,000. The trade was a 16.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Bitwise MARA Option Income Strategy ETF Price Performance

NYSEARCA:IMRA traded up $0.34 during trading hours on Thursday, reaching $14.46. The company’s stock had a trading volume of 1,889 shares, compared to its average volume of 5,966. The company has a market cap of $3.47 million, a price-to-earnings ratio of 289.20 and a beta of -6.67. Bitwise MARA Option Income Strategy ETF has a one year low of $11.99 and a one year high of $60.73. The business’s 50-day moving average is $14.89 and its 200-day moving average is $23.60.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.